LXEO stock results show that Lexeo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
PRLD Stock Earnings: Prelude Therapeutics Misses EPS for Q2 2024
PRLD stock results show that Prelude Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024
AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
ADAP Stock Earnings: Adaptimmune Therapeutics Beats EPS, Beats Revenue for Q2 2024
ADAP stock results show that Adaptimmune Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
LPTX Stock Earnings: Leap Therapeutics Misses EPS for Q2 2024
LPTX stock results show that Leap Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
BTDR Stock Earnings: Bitdeer Technologies Beats EPS, Misses Revenue for Q2 2024
BTDR stock results show that Bitdeer Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
TCRX Stock Earnings: TScan Therapeutics Meets EPS, Misses Revenue for Q2 2024
TCRX stock results show that TScan Therapeutics met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
